Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most common side effects of semaglutide injections are gastrointestinal — nausea, vomiting, diarrhoea and constipation. Most people experience them in the first few weeks of starting or after a dose increase, and they generally ease as the body adjusts. Semaglutide (sold as Wegovy for weight management) is a prescription-only medicine; a prescriber assesses your full health picture before it is dispensed. Knowing what to expect (and knowing the difference between a normal settling-in reaction and something that needs prompt medical attention) makes starting treatment far less daunting. This page covers both, drawing on NHS guidance on semaglutide and the medicine's official prescribing information.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Nausea is by far the most commonly reported effect. It tends to arrive in the day or two after an injection and often fades before the next weekly dose. Alongside nausea, people frequently notice loose stools or constipation (sometimes alternating) as well as indigestion, bloating, burping and, occasionally, vomiting. Fatigue and mild headaches are also reported, particularly around the early weeks of starting a weight-loss injection.
These effects are closely tied to how semaglutide works. By activating GLP-1 receptors, it slows how quickly food leaves your stomach and damps down appetite signals in the brain. That slower gastric emptying is useful for weight management, but the gut takes time to get used to it. Injection-site reactions (redness, itching, a small lump under the skin) affect a smaller proportion of users and are almost always mild. Rotating sites between the abdomen, thigh and upper arm each week helps keep reactions to a minimum.
The severity and frequency of Wegovy injection side effects tend to be worst at the 0.25mg and 0.5mg starting steps, when the system is adapting, and after each subsequent dose increase. The titration schedule (moving up roughly every four weeks) is specifically designed to give the body breathing room. For more on what the first injection feels like, including the timing of those early symptoms, we have a separate page.
Most people find that eating smaller meals, avoiding fatty or spicy foods and staying well hydrated significantly reduces nausea. Drinking water consistently throughout the day matters more than most expect.
Onset varies by person, but nausea usually appears within a few hours of the injection and peaks in the following 24 to 48 hours. For most, it has largely resolved by day four or five, well before the next weekly dose. Some people feel virtually nothing; others have a rougher first couple of weeks. There is no reliable way to predict which group you fall into beforehand.
Side effects of Wegovy injections do not always follow a neat pattern week to week. Many people have a noticeable reaction after dose one, much less after dose two, and a brief return when the dose steps up. That variation is normal. The timing of semaglutide side effects (including how long they typically last at each dose) is covered in more detail in a dedicated page.
If symptoms are still significantly disruptive after two to three weeks at a stable dose, that is worth raising with your prescriber. Staying on a lower dose for longer before stepping up is sometimes the right clinical decision. What you should not do is adjust timing or dosage yourself, those changes need a clinician's input, and the semaglutide Patient Information Leaflet on the eMC is the authoritative source for administration detail.
Most side effects are uncomfortable but not dangerous. Some, however, need prompt attention. Stop the injection and get medical help straight away if you develop:
If you are unsure, call 111. If symptoms are severe or you are in real doubt, go to A&E. You can also report suspected side effects (including unusual or serious ones) through the MHRA Yellow Card scheme, which exists precisely to build the post-market safety picture for medicines like this one.
A few practical factors seem to influence how noticeable the effects of semaglutide injections are. Eating a large, high-fat meal close to injection day tends to make nausea worse. Alcohol amplifies GI upset for many people. Starting the injection at a point when you are already stressed, poorly hydrated or dealing with another GI issue can make the first weeks harder than they need to be.
The pen itself, when it arrives in its plain DPD-tracked box from our pharmacy, comes with a full Patient Information Leaflet covering storage (the pen needs to be kept refrigerated at 2–8°C until first use), needle attachment and injection technique. Getting the injection technique right (letting the pen click fully, counting the seconds, rotating sites properly) genuinely reduces injection-site reactions. For safe disposal, a sharps container is the correct way to deal with used needles; household bins are not appropriate.
People using compounded or unlicensed semaglutide preparations face additional uncertainties around purity and dose accuracy, and if you are ever concerned about whether a pen is still fit to use, our page on what can happen with expired semaglutide explains the risks in detail. Our clinical team discusses suitability and side effects in full as part of every consultation; if you would like to explore whether treatment is appropriate for you, checking your eligibility is the natural starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.